Abstract
An open study was designed primarily to evaluate the efficacy of rosoxacin in the treatment of gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains. A total of 199 patients (99 men and 100 women) satisfactorily completed follow up examinations, 50 men and 50 women having received rosoxacin 300 mg orally and the remainder having received kanamycin 2 g intramuscularly. Rosoxacin achieved an overall cure rate of 94% (96.7% for PPNG and 90% for non-PPNG strains). In patients treated with kanamycin the overall cure rate was 89.9% (92.7% for PPNG and 83.3% for non-PPNG strains). A correlation between treatment failures and minimum inhibitory concentrations (MICs) of rosoxacin was noted in non-PPNG strains but not in PPNG strains. Side effects which were mild and self limiting were noted in 15 of 100 patients treated with rosoxacin. The high failure rates associated with non-PPNG strains requiring MICs of 0.125 mg/l and the observation of a substantial rise in the MICs for isolates after treatment is of concern. Otherwise, rosoxacin in a single dose of 300 mg appears to be safe and effective for the treatment of uncomplicated gonorrhoea.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bro-Jorgensen A., Jensen T. Single-dose oral treatment of gonorrhea in men and women, using ampicillin alone and combined with probenecid. Br J Vener Dis. 1971 Dec;47(6):443–447. doi: 10.1136/sti.47.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Calubiran O. V., Crisologo-Vizconde L. B., Tupasi T. E., Torres C. A., Limson B. M. Treatment of uncomplicated gonorrhoea in women. Comparison of rosoxacin and spectinomycin. Br J Vener Dis. 1982 Aug;58(4):231–235. doi: 10.1136/sti.58.4.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Handsfield H. H., Judson F. N., Holmes K. K. Treatment of uncomplicated gonorrhea with rosoxacin. Antimicrob Agents Chemother. 1981 Nov;20(5):625–629. doi: 10.1128/aac.20.5.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seth A. D. Sensitivity of gonococci to rosoxacin compared with that of penicillin, cefuroxime and tetracycline. J Antimicrob Chemother. 1981 Apr;7(4):331–334. doi: 10.1093/jac/7.4.331. [DOI] [PubMed] [Google Scholar]
- Sng E. H., Rajan V. S., Pang R., Yeo K. L. Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime. Br J Vener Dis. 1981 Jun;57(3):162–164. doi: 10.1136/sti.57.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sng E. H., Yeo K. L., Rajan V. S. Simple method for detecting penicillinase-producing Neisseria gonorrhoeae and Staphylococcus aureus. Br J Vener Dis. 1981 Apr;57(2):141–142. doi: 10.1136/sti.57.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warren C. A., Shannon K. P., Phillips I. In-vitro antigonococcal activity of rosoxacin (WIN 35213). Br J Vener Dis. 1981 Feb;57(1):33–35. doi: 10.1136/sti.57.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woscoff A., Flichman J. C., Man F., Martinez T. E., de Martinez L. R., Chouela E., Blanzaco D. P. Rosoxacin (Win 35,213) in the treatment of uncomplicated acute gonococcal infection. Clin Ther. 1982;4(6):515–525. [PubMed] [Google Scholar]